Q3 Revenue Wipeout and Near-Zero EBITDA Confirm FMC’s Structural Decline

What happened

FMC’s Q3 2026 results show revenue near a wipeout, confirming that aggressive repricing to clear excess distributor inventory has severely compressed both top line and margins. Net debt remains elevated at $3.3B–$3.6B, while 2026 EBITDA is projected near zero, pushing leverage ratios well beyond covenant limits and far above peers. This follows an already distressed 2025 where operating cash flow was negative $663M through nine months, total debt spiked to $4.54B, and management leaned on receivables factoring and commercial paper to fund operations. The India divestiture and manufacturing footprint redesign have failed to stabilize the business, and the revenue collapse indicates rapid share loss and pricing power erosion. Given these developments, the prior WAIT stance based on potential Latin America collections recovery is no longer viable, and the equity now reflects a distressed credit with limited recovery value.

Implication

Over the next 12 months, FMC faces a binary outcome: either a distressed debt restructuring or a drastic operational reset that further dilutes equity holders. Monitor receivables monetization levels and any new covenant amendments as early indicators of a liquidity crisis.

Thesis delta

Previously rated WAIT based on a possible cash recovery in 1H 2026 from Latin America collections. The Q3 2026 revenue wipeout and near-zero EBITDA guidance invalidate that premise. The thesis shifts to SELL/AVOID: the balance sheet is structurally overleveraged, and competitive erosion has outpaced cost-cut benefits.